Amazonas Florestal Ltd

PINK:AZFL USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.64 Million
Market Cap Rank
#51562 Global
#16215 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.89
About

Amazonas Florestal, Ltd operates and manages timber tracts. The company was formerly known as Ecologic Systems, Inc and changed its name to Amazonas Florestal, Ltd in 2012. Amazonas Florestal, Ltd was incorporated in 2008 and is based in Miami, Florida.

Amazonas Florestal Ltd (AZFL) - Net Assets

Latest net assets as of June 2022: $5.46 Million USD

Based on the latest financial reports, Amazonas Florestal Ltd (AZFL) has net assets worth $5.46 Million USD as of June 2022.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.51 Million) and total liabilities ($3.05 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $5.46 Million
% of Total Assets 64.15%
Annual Growth Rate N/A
5-Year Change 163.7%
10-Year Change N/A
Growth Volatility 44.9

Amazonas Florestal Ltd - Net Assets Trend (2009–2021)

This chart illustrates how Amazonas Florestal Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Amazonas Florestal Ltd (2009–2021)

The table below shows the annual net assets of Amazonas Florestal Ltd from 2009 to 2021.

Year Net Assets Change
2021-12-31 $4.86 Million +89.33%
2020-12-31 $2.57 Million 0.00%
2019-12-31 $2.57 Million +1.29%
2018-12-31 $2.53 Million +37.50%
2017-12-31 $1.84 Million +0.37%
2016-12-31 $1.84 Million +119.14%
2015-12-31 $837.89K +11.67%
2014-12-31 $750.35K +1350.58%
2011-12-31 $-60.00K -55.66%
2010-12-31 $-38.55K -105.09%
2009-12-31 $-18.79K --

Equity Component Analysis

This analysis shows how different components contribute to Amazonas Florestal Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 51318000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2021)

Component Amount Percentage
Retained Earnings $494.39K 10.17%
Common Stock $16.21 Million 333.50%
Other Comprehensive Income $4.37 Million 89.83%
Total Equity $4.86 Million 100.00%

Amazonas Florestal Ltd Competitors by Market Cap

The table below lists competitors of Amazonas Florestal Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Amazonas Florestal Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2020 to 2021, total equity changed from 3,262,556 to 4,859,935, a change of 1,597,379 (49.0%).
  • Net income of 494,386 contributed positively to equity growth.
  • Other comprehensive income increased equity by 1,798,694.
  • Other factors decreased equity by 695,701.

Equity Change Factors (2020 to 2021)

Factor Impact Contribution
Net Income $494.39K +10.17%
Other Comprehensive Income $1.80 Million +37.01%
Other Changes $-695.70K -14.32%
Total Change $- 48.96%

Book Value vs Market Value Analysis

This analysis compares Amazonas Florestal Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.33x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2009-12-31 $0.00 $0.00 x
2010-12-31 $0.00 $0.00 x
2011-12-31 $-3.00 $0.00 x
2014-12-31 $0.70 $0.00 x
2015-12-31 $0.33 $0.00 x
2016-12-31 $0.24 $0.00 x
2017-12-31 $0.00 $0.00 x
2018-12-31 $0.00 $0.00 x
2019-12-31 $0.00 $0.00 x
2020-12-31 $0.00 $0.00 x
2021-12-31 $0.00 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Amazonas Florestal Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 10.17%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 6.46%
  • • Asset Turnover: 1.00x
  • • Equity Multiplier: 1.58x
  • Recent ROE (10.17%) is above the historical average (-6.66%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2009 0.00% 0.00% 0.00x 0.00x $-16.91K
2010 0.00% 0.00% 0.00x 0.00x $-15.90K
2011 0.00% -62.45% 0.00x 0.00x $-38.69K
2014 -29.45% -49.08% 0.25x 2.40x $-296.03K
2015 0.00% 0.00% 0.12x 1.89x $-83.79K
2016 -2.82% 0.00% 0.00x 2.55x $-235.36K
2017 -31.18% -167.58% 0.06x 3.01x $-758.93K
2021 10.17% 6.46% 1.00x 1.58x $8.39K

Industry Comparison

This section compares Amazonas Florestal Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Amazonas Florestal Ltd (AZFL) $5.46 Million 0.00% 0.56x $0.91
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million